Clinical Trial Update: ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ESK981 in metastatic castration-resistant prostate cancer shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• ESK981

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-07-14